Bioxcel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical development company. The Company utilizes big data, machine learning, and artificial intelligence to identify the next wave of medicines across neuroscience, immuno-oncology, and related diseases. BioXcel Therapeutics serves customers in the State of Connecticut.
|Bank Name||BioXcel Therapeutics, Inc.|
|CEO||Dr. Vimal D. Mehta Ph.D.|